Loctite 7400 Varnistop

Hazard statements (CLP)

H225, H319, H336, H351

Code

Statements

H225

Highly Flammable liquid and vapour

SECTION 2: Hazards identification

Classification (CLP) Classification of the substance or mixture

2.2 Label elements

(CLP)

Contains

4-methylpentan-2-one n-butyl acetate

Signal word

Danger

Hazard statements

H225 Highly flammable liquid and vapour. H319 Causes serious eye irritation. H336 May cause drowsiness or dizziness. H351 Suspected of causing cancer.

Additional information

EUH066 Repeated exposure may cause skin dryness or cracking.

Precautionary statements

**" ***For consumer use only: P101 If medical advice is needed, have product container or label at hand. P102 Keep out of reach of children. P501 Dispose of contents/container in accordance with national regulation.*** P210 Keep away from heat, hot surfaces, sparks, open flames and other ignition sources. P337+P313 If eye irritation persists: Get medical advice/attention. P403+P235 Store in a well-ventilated place. Keep cool.

Prevention

No smoking. P261 Avoid breathing vapors. P280 Wear protective gloves/protective clothing.

Other hazards

None if used properly. Not fulfilling Persistent, Bioaccumulative and Toxic (PBT), very Persistent and very Bioaccumulative (vPvB) criteria. Following substances are present in a concentration >= 0,1% and fulfill the criteria for PBT/vPvB, or were identified as endocrine disruptor (ED) This mixture does not contain any substances in concentration ≥ the concentration limit that are assessed to be a PBT, vPvB or ED

2.1 Classification of the substance or mixture

Classification (CLP): Flammable liquids Category 2 H225 Highly flammable liquid and vapour. Serious eye irritation Category 2 H319 Causes serious eye irritation. Carcinogenicity Category 2 H351 Suspected of causing cancer. Specific target organ toxicity - single exposure Category 3 H336 May cause drowsiness or dizziness. Target organ: Central nervous system